Population pharmacokinetics and Bayesian dose adjustment to advance TDM of anti-TB drugs

MGG Sturkenboom, AG Märtson, EM Svensson… - Clinical …, 2021 - Springer
Tuberculosis (TB) is still the number one cause of death due to an infectious disease.
Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB …

[HTML][HTML] Tuberculosis of the spine

W Leowattana, P Leowattana… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Pott's spine, commonly known as spinal tuberculosis (TB), is an extrapulmonary form of TB
caused by Mycobacterium TB. Pott's paraplegia occurs when the spine is involved. Spinal …

Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems

AG Märtson, G Burch, S Ghimire… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Therapeutic drug monitoring (TDM) has been recommended for treatment
optimization in tuberculosis (TB) but is only is used in certain countries eg USA, Germany …

Population pharmacokinetics of linezolid in tuberculosis patients: dosing regimen simulation and target attainment analysis

WA Alghamdi, MH Al-Shaer, G An… - Antimicrobial agents …, 2020 - Am Soc Microbiol
The prolonged treatment duration for multidrug-resistant tuberculosis (MDR-TB) makes
linezolid dosing difficult because of adverse effects associated with long-term use. We …

Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium

AM Hogan, ASMZ Rahman, A Motnenko… - Nature …, 2023 - nature.com
The cell envelope of Gram-negative bacteria belonging to the Burkholderia cepacia complex
(Bcc) presents unique restrictions to antibiotic penetration. As a consequence, Bcc species …

[HTML][HTML] Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis

R Court, CM Centner, M Chirehwa, L Wiesner… - International Journal of …, 2021 - Elsevier
Background Cycloserine, or its structural analogue terizidone, has been associated with
neuropsychiatric toxicity (psychosis, depression, and neuropathy). Prospective clinical data …

Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens

Y Zhu, L Zhu, L Davies Forsman, J Paues… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Although cycloserine is a recommended drug for the treatment of multidrug-resistant
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …

Acyldepsipeptide analogues: a future generation antibiotics for tuberculosis treatment

SZZ Cobongela, MM Makatini, PS Mdluli, NRS Sibuyi - Pharmaceutics, 2022 - mdpi.com
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs),
which are currently explored for treatment of pathogenic infections, including tuberculosis …

[HTML][HTML] Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment

S Wang, LD Forsman, C Xu, H Zhang, Y Zhu… - International Journal of …, 2024 - Elsevier
Objectives This study aimed to investigate the association between drug exposure and
adverse events (AEs) during the standardized multidrug-resistant tuberculosis (MDR-TB) …

Therapeutic drug monitoring in tuberculosis

M Sarkar, J Sarkar - European Journal of Clinical Pharmacology, 2024 - Springer
Purpose Therapeutic drug monitoring (TDM) is a standard clinical procedure that uses the
pharmacokinetic and pharmacodynamic parameters of the drug in the body to determine the …